{"id":"https://genegraph.clinicalgenome.org/r/7f03f576-b44e-456b-9e95-c7ae21c0103ev1.1","type":"EvidenceStrengthAssertion","dc:description":"The PPP1R21 gene is located on chromosome 2p16.3 and encodes the Protein Phosphatase 1 Regulatory Subunit 21. PPP1R21 was first reported in relation to autosomal recessive neurodevelopmental disorder with hypotonia, facial dysmorphism and brain abnormalities (NEDHFBA) in 2018 Rehman et al. (PMID: 30520571). NEDHFBA is characterized by distinct facial dysmorphisms, intellectual disability, hypotonia, severe developmental delay and brain abnormalities. To date, 9 variants (including 3 nonsense, 5 frameshift and 1 splicing variants) have been reported in 9 probands in four publications and are included in this curation (PMID 29808498; 30520571; 32985083; 36692708). The mechanism of pathogenicity appears to be biallelic loss of function. Currently, there is limited experimental evidence to support the gene-disease association but other PP1 subunits have been linked to disease. In summary, there is strong evidence to support the relationship between PPP1R21 and autosomal recessive NEDHFBA. This classification is approved by the ClinGen Syndromic Disorders GCEP on the meeting date October 24, 2023 (SOP Version 9.0).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/7f03f576-b44e-456b-9e95-c7ae21c0103e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e","calculatedEvidenceStrength":"Strong","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2023-10-24T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-01-22T21:10:46.311Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec51e1be-c991-4110-8b50-576f815768b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a59bbfc7-1b28-4ac6-9d3f-4d0062cbed00","type":"Finding","dc:description":"Since other PP1 subunits have been linked to disease, the GCEP has elected to score this as biochemical evidence.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36692708","rdfs:label":"Hentschel_Biochemical Function","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf2d444a-8380-41bc-b7b0-84664d9f16c3","type":"EvidenceLine","dc:description":"Evidence is more for variant characterisation","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a6dfe1f-452e-4afd-963e-4343b4a16828","type":"FunctionalAlteration","dc:description":"Immunofluorescence analysis showed that PP1R21 consistently co-localized with early endosome marker EEA1 (Fig 2A). However, the staining pattern was absent from patient-derived fibroblast (Fig 2B). \nUptake and clearance of fluorescence labelled transferrin (transferrin-488) in patient-derived fibroblast (loss of function PPP1R21) showed unchanged transferrin uptake. However, mildly but statistically significantly delayed clearance was observed (Fig 3B), suggesting mild endo-lysosomal dysfunction","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Uptake and clearance of fluorescence labelled transferrin "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5613bb7a-8b97-4438-83ae-1652e34e7622","type":"EvidenceLine","dc:description":"Evidence is more for variant characterisation","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6aebb3cd-11b7-4396-aaac-b2b3297592fd","type":"FunctionalAlteration","dc:description":"Proteomic findings indicative for activation of ubiquitin-proteasome system\nTreatment with MG132 (proteasome inhibitors) showd pronounced activation of proteasome (Fig 4A) in patient-derived fibroblast - most likely correlates in terms of cellular attempt to elevate protein clearance capacity to facilitate break-down of protein aggregates \nMTT-assay revealed decreased cellular proliferation (Fig 4D) – observation in agreement with known function of PP1 in cell cycle regulation, accompanied with increased cellular toxicity burden (Fig 4E) \nAltered orientation of actin bundles and altered formation of filopodia in patient-derived fibroblast cytoskeleton (Fig 6B) – likely due to dysregulation of various proteins that play crucial role in proper cytoskeleton","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36692708","rdfs:label":"Investigation of proteasomal activity"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73ed552e-316f-428e-90e1-7b43ebfcc5e2","type":"EvidenceLine","dc:description":"phenotype not rescue by wild-type and phenotype of gene alteration is not consistent with human phenotype ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39a92b54-2737-49b0-9aa5-6ba0cfb47000","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37271428","rdfs:label":"Rescue of intrahepatic bile duct anomalies","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f0ba6a8c-8b56-4621-9fbe-226719f09052","type":"EvidenceLine","dc:description":"Autoimmune cholestatic liver disease is not reported in NEDHFBA so far","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/626c0810-1b54-4342-bdd8-4a1e1ea7c861","type":"Finding","dc:description":"Autoimmune cholestatic liver disease is not reported in NEDHFBA so far","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37271428","rdfs:label":"Zebrafish blg mutant ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c87037ed-f9f3-4142-b7dd-b86cb08ea68a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c87037ed-f9f3-4142-b7dd-b86cb08ea68a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 2_II-3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/51b7058c-bdff-41ad-a817-ecbcfcd20b48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.2170_2171insGGTA (p.Ile724ArgfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499226932"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0000280","obo:HP_0001263","obo:HP_0011968","obo:HP_0002389","obo:HP_0000369"],"previousTesting":true,"previousTestingDescription":"karyotyping and array CGH normal","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2818a18d-025c-4ecf-83aa-50953bb91b0e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","allele":{"id":"https://genegraph.clinicalgenome.org/r/51b7058c-bdff-41ad-a817-ecbcfcd20b48"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/2818a18d-025c-4ecf-83aa-50953bb91b0e","type":"EvidenceLine","dc:description":"NMD expected, downgraded as it is homozygous variant (consanguineous parent)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2818a18d-025c-4ecf-83aa-50953bb91b0e_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bc1517ba-bdce-4587-9e26-7066e51b9ff7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc1517ba-bdce-4587-9e26-7066e51b9ff7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 1_II-6","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/18dd37a9-9699-487b-bfa1-66f2af986f4d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.347del (p.Ile116LysfsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499216150"}},"phenotypes":["obo:HP_0000286","obo:HP_0002650","obo:HP_0001252","obo:HP_0000316","obo:HP_0001263","obo:HP_0000369"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7fb4b25a-caa5-499b-8457-9304830a30d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","allele":{"id":"https://genegraph.clinicalgenome.org/r/18dd37a9-9699-487b-bfa1-66f2af986f4d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7fb4b25a-caa5-499b-8457-9304830a30d2","type":"EvidenceLine","dc:description":"NMD expected, downgraded as it is homozygous variant (consanguineous parent)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fb4b25a-caa5-499b-8457-9304830a30d2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6d45eb4b-8222-4f4e-86e8-ed8502bd3e3f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d45eb4b-8222-4f4e-86e8-ed8502bd3e3f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29808498","rdfs:label":"Suleiman_Child 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/28d0ff3a-fa3e-4822-b2d6-7cf9bdcad366","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.87_88del (p.Gly30CysfsTer4)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499216163"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001583","obo:HP_0002650","obo:HP_0001371","obo:HP_0001320","obo:HP_0000218","obo:HP_0001252","obo:HP_0001263","obo:HP_0003196","obo:HP_0001265","obo:HP_0009765"],"previousTesting":true,"previousTestingDescription":"Chromosomal microarray and lysosomal storage next generation sequencing (NGS) panel","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/627aafbf-937b-459a-9ed4-0f28616ed239_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29808498","allele":{"id":"https://genegraph.clinicalgenome.org/r/28d0ff3a-fa3e-4822-b2d6-7cf9bdcad366"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/627aafbf-937b-459a-9ed4-0f28616ed239","type":"EvidenceLine","dc:description":"NMD expected, downgraded as it is homozygous variant (consanguineous parent)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/627aafbf-937b-459a-9ed4-0f28616ed239_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8e90b2ee-382c-4d45-b970-cd98d790778c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e90b2ee-382c-4d45-b970-cd98d790778c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32985083","rdfs:label":"Loddo_Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e8bb398f-1132-496d-9683-4288df1f92d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.193C>T (p.Arg65Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA46745758"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002650","obo:HP_0000280","obo:HP_0001320","obo:HP_0001252","obo:HP_0009937","obo:HP_0001263","obo:HP_0000574","obo:HP_0000286"],"previousTesting":true,"previousTestingDescription":"SNP array analysis detected no pathogenic CNV but revealed ROH in 2.78% ","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3ae83179-cd42-466a-a8d6-c88775ce1e1d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32985083","allele":{"id":"https://genegraph.clinicalgenome.org/r/e8bb398f-1132-496d-9683-4288df1f92d9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/3ae83179-cd42-466a-a8d6-c88775ce1e1d","type":"EvidenceLine","dc:description":"NMD expected (parent denied relatedness – they originated from small village of Southern Italy)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ae83179-cd42-466a-a8d6-c88775ce1e1d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/adaf4d5b-46de-4311-a151-c4ce7cc0febc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/adaf4d5b-46de-4311-a151-c4ce7cc0febc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29808498","rdfs:label":"Suleiman_Child 2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5b748b2b-ed61-4b8d-a808-a6f8e72e3c39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.427C>T (p.Arg143Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA46753668"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002079","obo:HP_0011968","obo:HP_0000369","obo:HP_0003196","obo:HP_0001252","obo:HP_0000218","obo:HP_0002389","obo:HP_0001320","obo:HP_0001263","obo:HP_0000316","obo:HP_0005469","obo:HP_0001265","obo:HP_0000431","obo:HP_0000280","obo:HP_0002098","obo:HP_0009937","obo:HP_0001583","obo:HP_0000574"],"previousTesting":true,"previousTestingDescription":"Chromosomal microarray","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0468c8c9-2cdb-406a-ad4f-c50152f922ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29808498","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b748b2b-ed61-4b8d-a808-a6f8e72e3c39"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/0468c8c9-2cdb-406a-ad4f-c50152f922ff","type":"EvidenceLine","dc:description":" NMD expected (parent were from same tribe)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0468c8c9-2cdb-406a-ad4f-c50152f922ff_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/b198836a-cbe4-44d7-98e7-da3999a97cae_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b198836a-cbe4-44d7-98e7-da3999a97cae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29808498","rdfs:label":"Suleiman_Child 1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a353d027-9966-404c-aafe-0b386b777e83","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.2089C>T (p.Arg697Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA46745762"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002389","obo:HP_0001583","obo:HP_0000431","obo:HP_0002240","obo:HP_0002098","obo:HP_0002079","obo:HP_0009937","obo:HP_0000280","obo:HP_0001263","obo:HP_0001265","obo:HP_0000218","obo:HP_0011968","obo:HP_0000369","obo:HP_0005469","obo:HP_0001320","obo:HP_0000574","obo:HP_0000316","obo:HP_0003196","obo:HP_0001252"],"previousTesting":true,"previousTestingDescription":"Chromosomal microarray","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/55d3b4af-1a90-41ed-a24e-7ca24f7ba3e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29808498","allele":{"id":"https://genegraph.clinicalgenome.org/r/a353d027-9966-404c-aafe-0b386b777e83"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/55d3b4af-1a90-41ed-a24e-7ca24f7ba3e6","type":"EvidenceLine","dc:description":"NMD expected, downgraded as it is homozygous variant (consanguineous parent)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55d3b4af-1a90-41ed-a24e-7ca24f7ba3e6_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cb738558-13e8-4488-adbc-98d5005888d9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb738558-13e8-4488-adbc-98d5005888d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36692708","rdfs:label":"Hentschel_Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/ea6a6c51-0ea0-4440-ab88-a7d7a33ea660","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.748-3A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA46757051"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"MRI at birth normal, MRI follow up at 1y showed periventricular leukomalacia (PVL)","phenotypes":["obo:HP_0001252","obo:HP_0001263","obo:HP_0000369","obo:HP_0002650"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c9e182c8-1cb6-40e4-be5c-9c7c0fb7d616_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36692708","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea6a6c51-0ea0-4440-ab88-a7d7a33ea660"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/c9e182c8-1cb6-40e4-be5c-9c7c0fb7d616","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9e182c8-1cb6-40e4-be5c-9c7c0fb7d616_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c9e182c8-1cb6-40e4-be5c-9c7c0fb7d616_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunoblotting showed complete loss of protein expression in patient fibroblasts compared to matched control (Fig 2C)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/27e7d945-a574-49d5-9e51-26aa74320963_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27e7d945-a574-49d5-9e51-26aa74320963","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 3_V-4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b03e2cbb-2fe8-4269-a6a1-8671270d41d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.1607dup (p.Leu536PhefsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499216155"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0000280","obo:HP_0002098","obo:HP_0009937","obo:HP_0002240","obo:HP_0000369","obo:HP_0001252"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cbe92533-a72a-4ab3-a7e8-a2db5225f65e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","allele":{"id":"https://genegraph.clinicalgenome.org/r/b03e2cbb-2fe8-4269-a6a1-8671270d41d1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/cbe92533-a72a-4ab3-a7e8-a2db5225f65e","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbe92533-a72a-4ab3-a7e8-a2db5225f65e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cbe92533-a72a-4ab3-a7e8-a2db5225f65e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"qPCR analyses revealed that PPP1R21 mRNA levels are greatly reduced, but not completely absent in patient fibroblast (Supp. Fig S7). Immunofluorescence analysis showed that PPP1R21 protein consistently co-localized with early endosome marker EEA1, however this staining pattern was absent from patient fibroblast (Fig 2B). ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/0093edc1-4f45-440a-afbb-01c436ba803e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0093edc1-4f45-440a-afbb-01c436ba803e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 4_IV-1","ageType":"AgeAtReport","ageUnit":"Months","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/243f2a86-e176-457e-86c8-878291bfde14","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001135629.3(PPP1R21):c.2063del (p.Lys688SerfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA916082530"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002098","obo:HP_0001320","obo:HP_0001252","obo:HP_0001263","obo:HP_0000280","obo:HP_0011968"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9a191ba9-d075-48b2-8080-1078cac825ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","allele":{"id":"https://genegraph.clinicalgenome.org/r/243f2a86-e176-457e-86c8-878291bfde14"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9a191ba9-d075-48b2-8080-1078cac825ea","type":"EvidenceLine","dc:description":"NMD expected, downgraded as it is homozygous variant (consanguineous parent)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a191ba9-d075-48b2-8080-1078cac825ea_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d8743574-2fe2-4819-a7bd-40e94d20065e_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a173b1d-798b-4f20-b175-42f3dc181469_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 affected individual with genotype in the family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 2","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/2a173b1d-798b-4f20-b175-42f3dc181469","type":"Family","rdfs:label":"Rehman_Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/c87037ed-f9f3-4142-b7dd-b86cb08ea68a"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"CNS anomalies","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002389","obo:HP_0011968","obo:HP_0000369","obo:HP_0001263","obo:HP_0001252","obo:HP_0000280"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c87037ed-f9f3-4142-b7dd-b86cb08ea68a"}},{"id":"https://genegraph.clinicalgenome.org/r/b8b9d98d-e3b7-44b1-a2b9-5b7fca73fc6b_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 affected individual with genotype in the family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/b8b9d98d-e3b7-44b1-a2b9-5b7fca73fc6b","type":"Family","rdfs:label":"Rehman_Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/bc1517ba-bdce-4587-9e26-7066e51b9ff7"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"CNS anomalies","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002098","obo:HP_0001263","obo:HP_0001252","obo:HP_0011968"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/bc1517ba-bdce-4587-9e26-7066e51b9ff7"}},{"id":"https://genegraph.clinicalgenome.org/r/adf43150-2531-459c-b6be-edc456e9be37_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 1 affected individual with genotype in the family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 3","estimatedLodScore":0.37,"family":{"id":"https://genegraph.clinicalgenome.org/r/adf43150-2531-459c-b6be-edc456e9be37","type":"Family","rdfs:label":"Rehman_Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/27e7d945-a574-49d5-9e51-26aa74320963"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"CNS anomalies","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000280","obo:HP_0000369","obo:HP_0002240","obo:HP_0001263","obo:HP_0001252","obo:HP_0009937","obo:HP_0002098"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/27e7d945-a574-49d5-9e51-26aa74320963"}},{"id":"https://genegraph.clinicalgenome.org/r/0d101c3b-dc19-4f8a-995c-c4cbf4190ea4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30520571","rdfs:label":"Rehman_Family 4","family":{"id":"https://genegraph.clinicalgenome.org/r/0d101c3b-dc19-4f8a-995c-c4cbf4190ea4","type":"Family","rdfs:label":"Rehman_Family 4","member":{"id":"https://genegraph.clinicalgenome.org/r/0093edc1-4f45-440a-afbb-01c436ba803e"}},"phenotypeFreeText":"CNS anomalies","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001263","obo:HP_0001252","obo:HP_0011968","obo:HP_0000280","obo:HP_0002098","obo:HP_0001320"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0093edc1-4f45-440a-afbb-01c436ba803e"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Strong","sequence":7691,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/9yQC58dS5Vw","type":"GeneValidityProposition","disease":"obo:MONDO_0859165","gene":"hgnc:30595","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d8743574-2fe2-4819-a7bd-40e94d20065e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}